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A b s t r a c t : The absorbance, fluorescence and phosphorescence characteristics 
of aristolochic acid, aristololactam, N-methyi aristoloiactam and aristololactam- 
/3-D-glucoside have been evaluated from their UV-visible spectra, determination 
of their emission and excitation spectra, quantum yield and the life time of 
their excited states. Biological activities of these compounds towards Ehrlich 
Ascites Carcinoma cells in Swiss Albino mice have been determined by (I) the 
trypan blue test, (ii) loss of transplantability, (iii) morphological changes 
and (iv) the incorporation of radiolabelled precursor into DNA, RNA and 
protein synthesis. Comparative studies show that the cytotoxic property Is 
In the order aristolochic acid (AA) aristololactam-^-D-glucoside (ADG) >  
aristololactam (AL) >  N-methyl aristololactam (ALM).
K e y w o r d s : Aristolochic acid, aristoloiactam, aristololactam-/9-D-glucoside, 
N-methyl aristololactam, Ehrlich ascites carcinoma cells, tumour cell-drug 
interaction.
P A C S N o :  87.15. Mi
I • Introduction
Aristolochia group of alkaloids and their glucoside derivatives have attracted 
recent attention for their antimicrobial, antitumour and various other biological 
properties (Kupchan and Doskotsch 1962, Kamatsh et al 1973, Chen and Zhu 1987). 
Some of the compounds of this group have been successively tested for the 
therapy of tuberculosis, chronic bronchitis, pneumococcal diseases and in the 
treatment of cancer (Chen and Zhu 1987, Cassady et al 1990). Recently, vve have 
shown that one of its derivatives aristololactam-^-D-glucoside interacts with DNA 
by a mechanism of Intercalation (Chakraborty ct al 1989a), however, the antitumour
•The author to whom correspondence should be addressed.
properties of some of the derivatives of Aristolochia group Including aristololactam, 
N-methyl 'aristololactam and aristololactam-^-D-glucoside (Figure 1) have not yet
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Chemical structure of (a) AA, (b) AL, (c) ALM  and (d) ADG.
been reported so far. Present study deals with some’ spectroscopic properties and 
biological activities of these compounds towards Ehrlich Ascites Carcinoma cells 
on a comparative methods.
2. Materials and methods
The phenanthrenic group of alkaloids used in this study were isolated and 
characterized (Chakraborty et of 1989b). Dimethyl sulphoxide (DM SO ), toluene, 
1, 4-bis (5-phenyl oxazolyl) (POPOP), 2,5-diphenyl oxazole (PPO) were obtained 
from Sigma Chemical Co., St. Louis, M .O., U .S .A . [*H] thymidine, [ ”H] uridine 
and [ ”H] leucine were obtained from Bhabha Atomic Research Centre, Bombay, 
RPMI 1640 medium with glutamine (without N a H C O j) vvere obtained from Gibco 
BRL, New York. The medium was dissolved in water containing 3.7 g/lit NaHCOg. 
A ll analytic grade chemicals and deionized double distilled water were used 
throughout.
Ehrlich Ascites Carcinoma (EAC ) cells were obtained by the courtsey of 
Chittaranjan National Cancer Research Centre, Calcutta and were maintained by 
weekly intraperitoneal transplantation in Swiss Albino mice (male) weighing 
18-22 g available from our Animal House Laboratory. EAC cells were harvested 
6-8 days after inoculation by intraperitoneai puncture. The celis and accompanying 
fluid were mixed with two volumes of deionized water to lyse any red cell present 
and the mixture was centrifuged at 2000 rpm for 3 mins. The supernatant fluid 
was decanted and discarded, and the packed tumour cells were resuspended in
0.145 M NaCI solution. Then the cells were further diluted to the desired cell 
count as measured by haemocytometer.
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Absorbance, fluorescence and phosphorescence measurements were done on a 
Shimadzu spectrophotometer model UV-260 (Shimadzu Corporation, Japan), Farrand 
system 3 (Farrand Optical Co., U SA ) spectrofluorimeter or Perkin-Elmer MPF 44A 
fluorimeter with phosphorescence attachment respectively. The details of the 
measurement procedure were described in (Maiti et a  I 1983, Chakraborty et a l  
1989b, Andley and Chakraborty 1982). Fluorescence quantum yields were 
calculated from the following equation as described (Maiti et a l 1983):
— (F».6<i.Cj/F(|.€gCg) xO.55 (1 )
where s and q denote sample and quinine sulphate in 0.1 N HaSO*, f  denotes the 
integral area of the fluorescence with excitation at the same wavelength, e is at the 
wavelength of excitation and C represents the corresponding concentrations.
Fluorescence life time ( r , )  measurements were carried out at 2 2 ’C on a 
modified Ortec 9200 nanosecond fluorimeter by analysis the following equation as 
described by Tao and Cho (1 9 7 9 ):
a
1/Tf =  2.88 X  10~*n*A» ^ «(A) dx (2)
where n, e and x are the refractive index of the solvent, the molar extinction 
coefficient and the wavelength of maximum absorption respectively.
Phosphorescence life time {t ,)  measurements were calculated from the 
phosphorescence decay curves using a recorder at 240 mm/min from the following 
equation :
Tp=t/lnC/o//)=1/K (3)
where /q and i are the intensity at time zero and at time t ; K is the decay constant.
Viability and morphological changes of the alkaloid treated EAC cells were 
examined under phase contrast with a Leitz Diaplan Scientific and clinical 
microscope, W . Germany with photographic attachment (Eaton et a I 1959, Bekesi 
et al 1969, Hazra et al 1984). Suspension (ether in 0.145 M saline or RPMI 
medium) of the harvested cells were incubated in presence and absence of alkaloids 
(cone. 20 A»g/10® cells/ml) for 1 hr at 37°C and were withdrawn at different time 
intervals. For viability test the viable cell (unstained by trypan blue) were counted 
by a haemocytometer. Viability was calculated as
Viability % = (T / C )x  100 (4)
where T  and C represent the surviving cells in a treated group and in untreated 
group respectively.
The effects of alkaloids on the transplantability of EAC cells was determined 
according to the procedure of Ritter et al (1987). After removal of extracellular 
alkaloids from the alkaloid treated cells the packed cells were suspended In
0.145 M NaCi solution and injected intraperitoneally into different groups (10 mice
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in each group) of mice (10® cells/mouse). The mean life span (M LS) of each 
group was observed. Increase in life span (ILS) of the mice in different groups in 
comparison to the saline control was calculated using the formula :
/ L S (% )= .[(T t/ T o )-1 ]x 1 0 0  (5)
where T ( and To are the survival time of the treated and untreated group 
respectively.
The effects of alkaloids on the macromolecular synthesis of DNA, RNA and 
protein were assessed by measuring cellular incorporation of tritiated thymidine, 
uridine and leucine from culture medium. EAC ce|ls (10® cells/ml) in presence 
or absence of alkaloids were incubated at 3 7 X  for 1 hr in a shaking water bath 
and [®H] thymidine or [®H] uridine or [®H] leucine (1 /iCi/ml) were added. After 
5 min intervals 1 ml of cell suspension was removed and diluted to 10 ml of PBS. 
Cells were then collected on Whatman GF/A glass microfibre filters and macro­
molecules were precipitated by the addition of cold 10% TC A . The residue were 
washed three times with 5 ml cold 5% TC A  and rinsed with 5 ml 90% ethanol and 
dried overnight. The radioactivity of the dried filters were determined in a 
scintillation fluid (of 4 gm of«PPO and 2 gm POPOP per litre toluene) using LKB 
Wallack 1217 RACK B ETA liquid Scintillation counter. The inhibition of incorpo­
ration is expressed as the difference in incorporation between alkaloid treated 
and control cells.
3. Results
Characteristic data for absorbance, fluorescence and phosphorescence are presented 
in Table 1. The fluorescence quantum yield is maximum for A L  and decreases
Table I . Absorbance, fluorescence and phosphorescence parameters of alkaloids.
Parameters AA AL ALM ADG
Absorption maxima (nm) 
(cx cm~^)
398 (6456) 
320 (13271) 
266 (21062)
398 (6309) 
330 (6841) 
290 (12770) 
259 (27421)
398 (6984) 
330 (7368) 
290 (13405) 
259 (34025)
398 (10930) 
330 (12004) 
290 (19295) 
259 (46954)
Fluorescence emission 
maximum (nm)
ND 486 485 485
^ p (x 0 -» ) ND 295 162 155
T, (ns) ND 9.1 8.4 8.1
Phosphorescence emission 
maximum (nm)
— 575, 630 575, 630 575, 630
Tp (8) — 0.45 0.50 0.65
ND =  Not detected.
in the order A L >  ALM  > A D G . It is interesting to note that the data of d>^  and r ,  
decrease in the order A L>  A LM  > A D G  while r ,  decreases in the reverse order.
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The data obtained from various biologicai experiments are presented in 
Table 2. it can be seen from the Table 2 that all alkaloids exhibits cytotoxic 
effect towards EAC cells. The viability percentage decreases in the order 
A A ^  A D G >  A L ^  A LM  while the transplantability Is affected maximum fo rA A  
and then decreases in the order A D G ^ A L )^ A L M  (Table 2). Morphological 
alterations of the EAC cells are observed in presence the alkaloids. After 1 hr 
treatment with AL, AO G  and A LM  (10 ^9/10" ceils) complete destruction of EAC 
cells is observed. In case of A D G , however, after 30 min treatment the EAC cells 
are found to be swollen. Very little morphological changes are observed in 
presence of A A .
Effect of the alkaloids on the macromolecular synthesis of EAC cells are 
studied and the summarized data are presented in Table 2. Time courses for 
synthesis of DNA is significantly affected with the alkaloids. The inhibition of 
D N A synthesis In the order A O G  > A L  > A LM  > A A  while RNA synthesis inhibition 
Is in the order ALM  > A L  > ADG and it Is unaffected with A A . The protein 
synthesis in the presence of the alkaloid is affected by a comparatively smaller 
degree except for A A  where the protein synthesis is inhibited by about 44% 
T ,  and Tj, data presented here could not be correlated with their biological 
properties.
4. Discussion
There are several approaches that might be used to test the effect of chemothera­
peutic drugs on cancer cells. Among them (i) measurement of morphological 
changes in tumour cells after drug exposure (Wright and Walker 1975, Balconi et 
al 1973), (ii) measurement of the increase in life span of test animals after 
implantation of drug treated tumour cells (Berry et al 1975, Salmon et al 1978, 
Ritter et al 1987), (ii) measurement of inhibition of cellular metabolism using 
radioactively labelled metabolic precursors (Philips 1974, Srivastava et al 1980) 
are often used. All these approaches have been utilized to test the antitumour 
effect of aristolochia group of alkaioids in the present study.
It can be seen from Table 2 that A A  shows significant antitumour effect as 
revealed from transplantabiliiy experiment with almost minimal effects towards 
morphological change, loss of viability and inhibition of D N A synthesis. Similar 
observation has been reported by Kamatsh et al (1973) that growth of mouse 
sarcoma 37 cells incubated with A A  was completely inhibited. It is interesting to 
note that A A  does not form any complex with D N A or RNA (unpublished observa­
tion). So the cellular activity of A A  may be due to some metabolite products of 
A A  which significantly interfere in curing of infected mouse.
In the present study A D G , A L  and A LM  showed some inhibitory effect towards 
the growth of EAC cells both In vivo and In vitro. The cells affer A D G  exposure 
ahowad swelling and subsequant disruption of cell structure ; while after AL and
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ALM  exposure, only disruption of cells had been observed. Cell survival as 
obtained from transplantability test is higher in ADG treated cells than with A L 
and ALM  treated ones. Similar effect has been observed by Elaterician A  and B 
(Gitter et al 1961) and various derivatives of Cucurbitacins (Gallily et al1962). 
Although A A  does not bind to DNA or RNA in vitro, it inhibits protein synthesis 
of EAC cells significantly while it has very little effect on DNA synthesis but no 
effect on RNA synthesis. The inhibition of thymidine and uridine incorporation 
suggest that all these lactans act in cellular level and binds to nucleic acid. 
Incorporation experiments with EAC cells indicate that AL, ADG and ALM  disrupt 
DNA and RNA synthesis with less effect on protein synthesis. This Is comparable 
to the effect of ellipticine (Li and Cow ie  1974). Interestingly, ADG show lower 
inhibitory effect on RNA synthesis than that on DNA synthesis in contrast to the 
intercalator adriamycin which inhibit DNA and RNA synthesis equally in intact 
cells. However, certain intercalating anthracyclines show more inhibition in DNA 
synthesis (Crooke et al 1981). Dercitin, a new acridine alkaloid isolated from a 
marine Dercitus species sponge shows greater inhibition of RNA synthesis (Burres 
et al 1989) and it is comparable to the data presented for AL. The binding of 
AD G  to DNA has been reported (Chakraborty et al 1989a, 1990) and similar 
binding of AL, ALM  has been observed (unpublished). Thus, the incorporation 
studies are in agreement with the intracellular binding of A L, ALM, ADG to nucleic 
acid and explain the disruption of the integrity of the cell.
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